Mechanistic Insights Into Aging And Longevity: Implications For Ovarian Function And Health
As women age, their ovaries undergo a process of decline, characterized by a reduction in the number of available eggs, issues with the energy-producing parts of cells called mitochondria, an increase in harmful cellular stress, and a decrease in hormone production. This complex process is influenced by several key factors. For instance, the protective caps at the ends of chromosomes, known as telomeres, become shorter over time, and DNA can accumulate damage. Additionally, the body’s natural cellular recycling process, called autophagy, can become impaired, and chronic inflammation can contribute to the problem. Important pathways that regulate how long cells live, such as PI3K/AKT/mTOR, AMPK, and sirtuins, also play a significant role. When these interconnected systems are disrupted, it can accelerate the activation of egg-containing structures, lead to the death of supporting cells around the eggs, and diminish the overall quality of the eggs. Researchers are exploring various interventions to address these issues. These include drugs that can inhibit mTOR, activate AMPK, and substances that act as antioxidants to combat cellular damage. Other promising approaches involve compounds that protect mitochondria and regulate autophagy. Specific compounds like rapamycin, metformin, resveratrol, and melatonin have shown potential in preclinical and early clinical studies. Alongside these pharmacological approaches, lifestyle adjustments and nutritional changes can also be beneficial. A deeper understanding of these underlying mechanisms is vital for developing precise strategies to delay the onset of menopause, preserve fertility, and ultimately enhance women’s overall health and well-being as they age.
Source: link to paper